Stem cell therapy for muscular dystrophy

Author： Sohn Regina Lee Gussoni Emanuela

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.4, Iss.1, 2004-01, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for muscular dystrophy – a review ofpromising progress

By Gregorevic Paul Chamberlain Jeffrey S

Expert Opinion on Biological Therapy, Vol. 3, Iss. 5, 2003-08 ,pp. : 803-814

Informa Healthcare

Access to resources Recommend Favorite

AAV-directed muscular dystrophy gene therapy

By Tang Ying Cummins James Huard Johnny Wang Bing

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

By Yokota Toshifumi Pistilli Emidio Duddy William Nagaraju Kanneboyina

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 831-842

Informa Healthcare

Access to resources Recommend Favorite

Developing Effective Therapy for Duchenne Muscular Dystrophy (DMD): Challenges and Promises

Current Chemical Biology, Vol. 8, Iss. 3, 2014-01 ,pp. : 117-131

Bentham Science Publishers

Access to resources Recommend Favorite

Current advances in cell therapy strategies for muscular dystrophies

By Negroni Elisa Vallese Denis Vilquin Jean-Thomas Butler-Browne Gillian Mouly Vincent Trollet Capucine

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 157-176

Informa Healthcare

Access to resources Recommend Favorite